SPOTLIGHT -
A brief discussion of dose increase versus unchanged continuation of antidepressants after initial treatment failure in patients with depression.
sNDA Submitted: Spravato as Monotherapy for Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Which Antidepressant Causes the Least Amount of Weight Gain?
Treating ‘Morally Objectionable’ Patients
The Potential of Ketamine: Public Workshop and New Research Explores Uses
The Week in Review: June 17-21